| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/28/2005 | US6911456 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911444 Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors |
| 06/28/2005 | US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911199 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/28/2005 | CA2402300C Fluorocarbon aerosol medicaments |
| 06/23/2005 | WO2005056527A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 06/23/2005 | WO2005055999A1 Anticholinergic agent |
| 06/23/2005 | WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005037224A3 Muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2004041258A8 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/23/2005 | US20050137414 New aminopropylphosphinic acids |
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137242 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050136133 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 06/23/2005 | US20050136067 Multimeric hybrid gene having a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen, especially coding for a parainfluenza virus and a respiratory syncytial virus; vaccines |
| 06/23/2005 | US20050136010 Treatment of chronic obstructive pulmonary disease, by administering inhalant with particulate carrier or diluent selecting from saccharide, a sugar alcohol or lactose, in an amount of from 400 mu g to 5000 mu g per mu g of active ingredient |
| 06/23/2005 | DE10356248A1 Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden A pharmaceutical composition for the treatment of rhinitis |
| 06/23/2005 | CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2548901A1 Use of goat blood serum derived antibodies obtained after challenge with hiv lysate for veterinary treatment |
| 06/23/2005 | CA2548602A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1543833A1 Phosphorylated dextran |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1542987A1 Piperidine-n-oxide-derivatives |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542904A1 Process for producing metered dose inhaler formulations |
| 06/22/2005 | EP1542753A1 Pharmaceutical compositions |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542666A1 Modafinil pharmaceutical compositions |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1173160B1 (e)-styryl sulfone anticancer agents |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630649A Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/22/2005 | CN1630638A Aryl ureas as kinase inhibitors |
| 06/22/2005 | CN1630637A Novel arylheteroalkylamine derivatives |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630535A Inhibition of STAT-1 |
| 06/22/2005 | CN1630526A Systems and methods for treating patients with processed lipoaspirate cells |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1629182A Oslasodine hydrochloride preparing process |
| 06/22/2005 | CN1628838A Composite formulation for treating bronchial asthma |
| 06/22/2005 | CN1628799A Clove leaf extract containing soft capsule and its preparation process |
| 06/22/2005 | CN1628784A Compound fineleaf schizonepeta oil soft capsule |
| 06/22/2005 | CN1628770A Cough stopping and asthma relieving medicine and its preparation |
| 06/22/2005 | CN1628764A Creat formulation and its preparation process |
| 06/22/2005 | CN1628761A Medicine for treating rhinitis and its preparing process |
| 06/22/2005 | CN1628707A Cough stopping liquor |
| 06/22/2005 | CN1628699A Chicken gallbladder extractum dispersible tablet and its preparation process |
| 06/22/2005 | CN1628693A Glossy ganoderma preparation containing main active substance of glossy ganoderma herb and preparing method thereof |
| 06/22/2005 | CN1628667A Compound dried suspension of dextromethorphan and gualfenesin and preparation method thereof |
| 06/22/2005 | CN1628666A Dispersive tablet of montelukast sodium |
| 06/22/2005 | CN1628660A Externally used liquid preparation containing fibrauretine and its application on genital tract, oral cavity and upper respiratory tract |
| 06/22/2005 | CN1628655A Andrographolide dispersed tablet and preparation method thereof |
| 06/22/2005 | CN1628647A 盐酸氨溴索颗粒剂 Ambroxol Hydrochloride Granules |
| 06/22/2005 | CN1628645A Ambroxol hydrochloride oral disintegrating tablet and preparation method thereof |
| 06/22/2005 | CN1628643A Manufacturing method for snore relieving paster and equipment thereof |
| 06/22/2005 | CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents |
| 06/22/2005 | CN1207057C Anti-sphagitis specificity composite IgY and preparation thereof |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/22/2005 | CN1207050C Chinese medicine for treating chronic nasitis and its production method |
| 06/22/2005 | CN1207032C Chinese medicine composition for curing acute and chronic rhinorrhea with turbid discharge and its preparation method |
| 06/22/2005 | CN1207030C Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity |
| 06/22/2005 | CN1207019C Multifunctional paster |
| 06/22/2005 | CN1206991C Preparation containing Cetirizine Hydrochloride and hydrochloric pseudoephedrine and its prepn. method |
| 06/21/2005 | US6909007 Steroidal pharmaceutical compounds |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908917 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |
| 06/21/2005 | CA2213339C Method of treating adenosine depletion |
| 06/16/2005 | WO2005054432A2 Gene transfer for regulating smooth muscle tone |
| 06/16/2005 | WO2005054252A1 Crystal of hydrochloride of sulfoxide derivative |
| 06/16/2005 | WO2005054249A1 Novel compounds |
| 06/16/2005 | WO2005053648A1 Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 06/16/2005 | WO2005053647A1 Medical product containing tiotropium |
| 06/16/2005 | WO2005025540A3 Mucoactive agents for treating a pulmonary disease |
| 06/16/2005 | WO2005007144A3 Method of diagnosis and treatment for asthma based on haplotype association |
| 06/16/2005 | WO2004099782A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases |
| 06/16/2005 | US20050131200 Biocompatability; polyphosphoester/polyphosphoramidate linkages; improved gene delivery into muscles; DNA vaccines |
| 06/16/2005 | US20050131064 Administering powder or aerosol to nasal mucous membrane |
| 06/16/2005 | US20050131035 Medicaments |